OrphanDrug
OrphanDrug
Pharma Knowledge Base

hyperkalemic periodic paralysis

MeSH: D020513ORPHA: 682

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with hyperkalemic periodic paralysis, sourced from HPO and Orphanet clinical annotations.

OphthalmoparesisHypertoniaGait disturbanceReduced tendon reflexesFlexion contractureCongestive heart failureMalignant hyperthermiaRespiratory insufficiencyHyperkalemiaFasciculationsMyotoniaBowel incontinenceHypokalemiaHyponatremiaMyopathySkeletal muscle atrophyElevated circulating creatine kinase concentrationMyalgiaParesthesiaEMG abnormalitySkeletal muscle hypertrophyEpisodic flaccid weaknessPeriodic hyperkalemic paralysisFeeding difficulties in infancyArrhythmiaCerebral palsyChest pain

Classification & Codes

MeSH Code

D020513

Orphanet Code

ORPHA:682
hyperkalemic periodic paralysis
MeSHD020513
OrphanetORPHA:682
Treatments0 drug(s)
Symptoms on record27 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO